Acné – 1999

Update on acne therapy.
O’Donoghue MN.
Dermatol Nurs. 1999 Jun;11(3):205-8. Review.

A new treatment option for acne scars: allograft dermis.
Besecker B, Hart CG.
Dermatol Nurs. 1999 Apr;11(2):111-4. Review.

Severe hypersensitivity reaction to minocycline.
de Paz S, Pérez A, Gómez M, Trampal A, Domínguez Lázaro A.
J Investig Allergol Clin Immunol. 1999 Nov-Dec;9(6):403-4.

[Acne 1999: do we still need the dermatologist?].
Fanta D, Messeritsch-Fanta C.
Hautarzt. 1999 Dec;50(12):900-11; quiz 911. Review. German.

Azithromycin for the treatment of acne.
Fernandez-Obregon AC.
Int J Dermatol. 2000 Jan;39(1):45-50.

Sebum excretion rates in mothers and neonates.
Henderson CA, Taylor J, Cunliffe WJ.
Br J Dermatol. 2000 Jan;142(1):110-1.

[Mucosa and skin anomalies of the newborn].
Plantin P.
Ann Dermatol Venereol. 1999 Dec;126(12):927-32. Review. French.

Topical treatment of acne vulgaris for the nurse practitioner.
Duvauchelle SA.
Clin Excell Nurse Pract. 1999 May;3(3):141-8. Review.

Acne therapy.
White GM.
Adv Dermatol. 1999;14:29-58; discussion 59. Review.

L-carnitine supplementation in patients with cystic acne on isotretinoin therapy.
Georgala S, Schulpis KH, Georgala C, Michas T.
J Eur Acad Dermatol Venereol. 1999 Nov;13(3):205-9.

Metronidazole, its bioactive metabolites and acne.
Bannatyne RM.
Curr Med Res Opin. 1999;15(4):298-9.

Polymorphism at codon 554 of the human Ah receptor: different allelic frequencies in Caucasians and Japanese and no correlation with severity of TCDD induced chloracne in chemical workers.
Wanner R, Zober A, Abraham K, Kleffe J, Henz BM, Wittig B.
Pharmacogenetics. 1999 Dec;9(6):777-80.

Complications of minocycline therapy for acne vulgaris: case reports and review of the literature.
Somech R, Arav-Boger R, Assia A, Spirer Z, Jurgenson U.
Pediatr Dermatol. 1999 Nov-Dec;16(6):469-72. Review.

The frequency of common nonmalignant skin conditions in adults in central Victoria, Australia.
Plunkett A, Merlin K, Gill D, Zuo Y, Jolley D, Marks R.
Int J Dermatol. 1999 Dec;38(12):901-8.

[Current approaches to the topical treatment of acne vulgaris].
Vovk OB.
Lik Sprava. 1999 Sep;(6):107-10. Review. Ukrainian.

Acne and rosacea. New and emerging therapies.
Thiboutot DM.
Dermatol Clin. 2000 Jan;18(1):63-71, viii. Review.

SAPHO syndrome: a long-term follow-up study of 120 cases.
Hayem G, Bouchaud-Chabot A, Benali K, Roux S, Palazzo E, Silbermann-Hoffman O, Kahn MF, Meyer O.
Semin Arthritis Rheum. 1999 Dec;29(3):159-71.

Guess what? Macronodular iatrogenic acne due to amineptine.
Grimalt R, Mascaró-Galy JM, Ferrando J, Lecha M.
Eur J Dermatol. 1999 Sep;9(6):491-2.

Isotretinoin therapy for antibiotic-refractory acne in Apert’s syndrome.
Downs AM, Condon CA, Tan R.
Clin Exp Dermatol. 1999 Nov;24(6):461-3.

In-vitro and in-vivo efficacy of zinc acetate against propionibacteria alone and in combination with erythromycin.
Fluhr JW, Bösch B, Gloor M, Höffler U.
Zentralbl Bakteriol. 1999 Oct;289(4):445-56.

Failure of colchicine in the treatment of severe acne vulgaris.
Schepis C, Siragusa M, Palazzo R, Guerra AP.
Acta Derm Venereol. 1999 Nov;79(6):491.

[Apropos of recommendations concerning oral treatment of acne. An interview with the president S. Belaich. Interview by Hélne Allouch].
Belaich S.
Presse Med. 1999 Nov 27;28(37):2046-7. French.

[Oral treatment of acne. Agence Française de Securité Sanitaire des Produits de Santé].
[No authors listed]
Presse Med. 1999 Nov 27;28(37):2044-5. French.

Minocycline-induced clinical and biological lupus-like disease.
Tournigand C, Généreau T, Prudent M, Diemert MC, Herson S, Chosidow O.
Lupus. 1999;8(9):773-4.

Newer concepts in antimicrobial therapy.
Parish LC.
Adv Exp Med Biol. 1999;455:397-406. Review.

Clinical pharmacokinetics and drug metabolism of tazarotene: a novel topical treatment for acne and psoriasis.
Tang-Liu DD, Matsumoto RM, Usansky JI.
Clin Pharmacokinet. 1999 Oct;37(4):273-87. Review.

Prolonged clinical and histologic effects from CO2 laser resurfacing of atrophic acne scars.
Walia S, Alster TS.
Dermatol Surg. 1999 Dec;25(12):926-30.

Regarding dermabrasion for acne scars.
Langdon RC.
Dermatol Surg. 1999 Nov;25(11):919-20.

A placebo-controlled clinical trial to compare a gel containing a combination of isotretinoin (0.05%) and erythromycin (2%) with gels containing isotretinoin (0.05%) or erythromycin (2%) alone in the topical treatment of acne vulgaris.
Glass D, Boorman GC, Stables GI, Cunliffe WJ, Goode K.
Dermatology. 1999;199(3):242-7.

[Finasteride: also effective in acne vulgaris?].
Wolff H.
Hautarzt. 1999 Nov;50(11):815. German.

Low dose flutamide in the treatment of acne vulgaris in women with or without oligomenorrhea or amenorrhea.
Wang HS, Wang TH, Soong YK.
Changgeng Yi Xue Za Zhi. 1999 Sep;22(3):423-32.

Isotretinoin treatment for acne vulgaris and its cutaneous and ocular side-effects.
Azurdia RM, Sharpe GR.
Br J Dermatol. 1999 Nov;141(5):947.

Acute severe acne in a female patient (acne fulminans?)
Jansen T, Romiti R, Plewig G.
Br J Dermatol. 1999 Nov;141(5):945-7.

Oral trimethoprim: a relatively safe and successful third-line treatment for acne vulgaris.
Cunliffe WJ, Aldana OL, Goulden V.
Br J Dermatol. 1999 Oct;141(4):757-8.

Blood lipid concentrations of dioxins and dibenzofurans causing chloracne.
Coenraads PJ, Olie K, Tang NJ.
Br J Dermatol. 1999 Oct;141(4):694-7.

The treatment of acne agminata with clofazimine.
Seukeran DC, Stables GI, Cunliffe WJ, Sheehan-Dare RA.
Br J Dermatol. 1999 Sep;141(3):596-7.

Light cautery of macrocomedones under general anaesthesia.
Thomson KF, Goulden V, Sheehan-Dare R, Cunliffe WJ.
Br J Dermatol. 1999 Sep;141(3):595-6.

A study of the spectrum of skin disease occurring in a black population in south-east London.
Child FJ, Fuller LC, Higgins EM, Du Vivier AW.
Br J Dermatol. 1999 Sep;141(3):512-7.

Delivery of erythromycin to subcutaneous tissues in rats by means of a trans-phase delivery system.
Peng L, Nimni ME.
J Pharm Pharmacol. 1999 Oct;51(10):1135-41.

Topical corticosteroid-induced acne. Three treatment strategies to break the ‘addiction’ cycle.
Brodell RT, O’Brien MJ Jr.
Postgrad Med. 1999 Nov;106(6):225-6, 229.

[Autoimmune hepatitis and lupus syndrome associated with minocycline].
Dadamessi I, Leduc I, Duché A, Tiev K, Barbieux D, Sevestre H, Andréjak M, Ducroix JP.
Rev Med Interne. 1999 Oct;20(10):930-3. French.

[Systemic reaction induced my minocycline treatment: a report of four patients and a review of the literature].
Piette AM, Ramanoelina J, Gepner P, Larroche C, Blétry O.
Rev Med Interne. 1999 Oct;20(10):869-74. Review. French.

[Acute acne fulminans et conglobata after the end of high-dose testosterone therapy for hereditary tall stature].
Weimann E, Böhles HJ.
Klin Padiatr. 1999 Sep-Oct;211(5):410-2. German.

Night blindness precipitated by isotretinoin in the setting of hypovitaminosis A.
Welsh BM, Smith AL, Elder JE, Varigos GA.
Australas J Dermatol. 1999 Nov;40(4):208-10.

[Prediction of increased levels of androgen in women with acne vulgaris using ultrasound and clinical parameters].
Cibula D, Hill M, Fanta M, Skrenková J, Vohradníková O, Kudynová J, Zivný J.
Ceska Gynekol. 1999 Jul;64(4):242-6. Czech.

Psychological and sympatho-adrenal status in patients with cystic acne.
Schulpis K, Georgala S, Papakonstantinou ED, Michas T.
J Eur Acad Dermatol Venereol. 1999 Jul;13(1):24-7.

Clinical efficacy and safety of a topical combination of retinaldehyde 0.1% with erythromycin 4% in acne vulgaris.
Morel P, Vienne MP, Beylot C, Bonérandi JJ, Dréno B, Lehucher-Ceyrac D, Slimani S, Dupuy P.
Clin Exp Dermatol. 1999 Sep;24(5):354-7.

Localised facial swelling associated with isotretinoin.
Patel GK, Chowdhury MM, Clark SM, Knight AG.
Dermatology. 1999;199(2):196.

Minocycline and autoimmunity.
Eichenfield AH.
Curr Opin Pediatr. 1999 Oct;11(5):447-56. Review.

Acne management guideline, 1999. South African Medical Association-Dermatological Society of South Africa Working Group.
[No authors listed]
S Afr Med J. 1999 Sep;89(9 Pt 2):1024-34.

[Acne and its treatment possibilities].
Böni R, Hafner J, Krasovec M.
Schweiz Med Wochenschr. 1999 Oct 16;129(41):1496-503. Review. German.

In vitro dermal and transdermal delivery of doxycycline from ethanol/migliol 840 vehicles.
Perkins NC, Heard CM.
Int J Pharm. 1999 Nov 15;190(2):155-64.

The misery of acne: a look at the treatment options.
Preston D.
Community Nurse. 1999 Aug;5(7):13-4.

Management of acne vulgaris.
Murphy G.
Ir Med J. 1999 Aug;92(5):360-1.

Olestra increases faecal excretion of 2,3,7,8-tetrachlorodibenzo-p-dioxin.
Geusau A, Tschachler E, Meixner M, Sandermann S, Päpke O, Wolf C, Valic E, Stingl G, McLachlan M.
Lancet. 1999 Oct 9;354(9186):1266-7.

[The effectiveness of oral cyproterone acetate in combination with ethinylestradiol in acne tarda of the facial type].
Gollnick H, Albring M, Brill K.
Ann Endocrinol (Paris). 1999 Sep;60(3):157-66. French.

Acute anterior uveitis in a patient with sacroiliitis and acne conglobata.
Villaverde V, Munñoz-Fernández S, Hidalgo V, Cortés I, Fonseca A, Gijón-Baños J, Martín-Mola E.
Rheumatology (Oxford). 1999 Aug;38(8):797-8.

[Acne vulgaris as a therapeutic problem].
Brzezinska-Wcislo L.
Wiad Lek. 1999;52(3-4):168-73. Polish.

Alcohol intake and other skin disorders.
Higgins E, du Vivier A.
Clin Dermatol. 1999 Jul-Aug;17(4):437-41. Review.

[Acne fulminans after the treatment with isotretinoin].
López-Vílchez MA, Vicente Villa MA, García-Fructuoso MT, Manzanares Bahí R, González Enseñat MA.
An Esp Pediatr. 1999 Aug;51(2):200-2. Spanish.

Prevalence of facial acne in adults.
Goulden V, Stables GI, Cunliffe WJ.
J Am Acad Dermatol. 1999 Oct;41(4):577-80.

Topical treatments in acne vulgaris.
Malcolm B.
Practitioner. 1998 Apr;242(1585):300-1. Review.

Acne vulgaris: state of the science.
Webster GF.
Arch Dermatol. 1999 Sep;135(9):1101-2.

Androgen metabolism in sebaceous glands from subjects with and without acne.
Thiboutot D, Gilliland K, Light J, Lookingbill D.
Arch Dermatol. 1999 Sep;135(9):1041-5.

Acne therapy.
White GM.
Dis Mon. 1999 Aug;45(8):301-30. Review.

Extraspinal enthesopathy caused by isotretinoin therapy.
Brandt JR, Mick TJ.
J Manipulative Physiol Ther. 1999 Jul-Aug;22(6):417-20.

Densitometric thin layer chromatographic analysis of tretinoin and erythromycin in lotions for topical use in acne treatment.
Gabriëls M, Brisaert M, Plaizier-Vercammen J.
Eur J Pharm Biopharm. 1999 Jul;48(1):53-8.

Acne fulminans in late-onset congenital adrenal hyperplasia.
Placzek M, Degitz K, Schmidt H, Plewig G.
Lancet. 1999 Aug 28;354(9180):739-40.

Acne and acne scarring: why should we treat?
Goodman GJ.
Med J Aust. 1999 Jul 19;171(2):62-3.

Comedolytic effect of topical retinaldehyde in the rhino mouse model.
Fort-Lacoste L, Verscheure Y, Tisne-Versailles J, Navarro R.
Dermatology. 1999;199 Suppl 1:33-5.

Topical retinoids in the treatment of acne vulgaris.
Bershad S, Poulin YP, Berson DS, Sabean J, Brodell RT, Shalita AR, Kakita L, Tanghetti E, Leyden J, Webster GF, Miller BH.
Cutis. 1999 Aug;64(2 Suppl):8-20; quiz 21-3. Review.

The cost-effectiveness of isotretinoin in the treatment of acne. Part 3. A cost-minimisation pharmaco-economic model.
Wessels F, Anderson AN, Kropman K.
S Afr Med J. 1999 Jul;89(7 Pt 2):791-4.

The cost-effectiveness of isotretinoin in the treatment of acne. Part 2. A chronic medication plan profiling study.
Wessels F, Anderson AN, Kropman K.
S Afr Med J. 1999 Jul;89(7 Pt 2):785-90.

The cost-effectiveness of isotretinoin in the treatment of acne. Part 1. A meta-analysis of effectiveness literature.
Wessels F, Anderson AN, Kropman K.
S Afr Med J. 1999 Jul;89(7 Pt 2):780-4.

Resurfacing the acne-scarred face.
Fulton JE Jr, Silverton K.
Dermatol Surg. 1999 May;25(5):353-9.

The treatment of acne fulminans: a review of 25 cases.
Seukeran DC, Cunliffe WJ.
Br J Dermatol. 1999 Aug;141(2):307-9.

The familial risk of adult acne: a comparison between first-degree relatives of affected and unaffected individuals.
Goulden V, McGeown CH, Cunliffe WJ.
Br J Dermatol. 1999 Aug;141(2):297-300.

Recalcitrant acne vulgaris secondary to a dental abscess.
Boyd AS, King LE Jr.
Cutis. 1999 Aug;64(2):116-8.

An infectious mononucleosis-like syndrome induced by minocycline: a third pattern of adverse drug reaction.
Lupton JR, Figueroa P, Tamjidi P, Berberian BJ, Sulica VI.
Cutis. 1999 Aug;64(2):91-6.

Arthropathy associated with cystic acne, hidradenitis suppurativa, and perifolliculitis capitis abscedens et suffodiens: treatment with isotretinoin.
Libow LF, Friar DA.
Cutis. 1999 Aug;64(2):87-90.

Therapy at its best.
McCarthy JT.
Cutis. 1999 Aug;64(2):82.

Chloracne, goiter, arthritis, and anemia after polychlorinated biphenyl poisoning: 14-year follow-Up of the Taiwan Yucheng cohort.
Guo YL, Yu ML, Hsu CC, Rogan WJ.
Environ Health Perspect. 1999 Sep;107(9):715-9.

The inter-relationship between isotretinoin/acne and depression.
Chu A, Cunliffe WJ.
J Eur Acad Dermatol Venereol. 1999 May;12(3):263.

Bone densities in patients receiving isotretinoin for cystic acne.
Leachman SA, Insogna KL, Katz L, Ellison A, Milstone LM.
Arch Dermatol. 1999 Aug;135(8):961-5.

[Widely disseminated ectopic acne].
De Bruin-Weller MS, Van Vloten WA, Werker P.
Ned Tijdschr Geneeskd. 1999 Jun 19;143(25):1340-1. Dutch.

Acute arthritis after isotretinoin.
Lehucher Ceyrac D.
Dermatology. 1999;198(4):406-7.

Cost-effectiveness of oral isotretinoin.
Honein MA, Paulozzi LJ.
Dermatology. 1999;198(4):404-6.

[Use and adverse reactions of local antibiotics and disinfectants on the skin].
Keppel Hesselink JM.
Ned Tijdschr Geneeskd. 1999 Jul 10;143(28):1491. Dutch.

The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients.
Kim SM, Lee HS, Hann SK.
Int J Dermatol. 1999 Jul;38(7):546-50.

SAHA syndrome: female androgenetic alopecia and hirsutism.
Camacho FM.
Exp Dermatol. 1999 Aug;8(4):304-5.

[Acne vulgaris: local and systemic treatment].
Kwiecien A, Zalewska A.
Pol Merkur Lekarski. 1999 May;6(35):291-3. Review. Polish.

Acne: a review of immunologic and microbiologic factors.
Burkhart CG, Burkhart CN, Lehmann PF.
Postgrad Med J. 1999 Jun;75(884):328-31. Review.

Do some men with acne vulgaris have raised levels of LH?
Farrell A, Alaghband-Zadeh J, Carter G, Newson RB, Cream JJ.
Clin Endocrinol (Oxf). 1999 Mar;50(3):393-7.

Prevalence of skin disease in a cohort of shelter-based homeless men.
Stratigos AJ, Stern R, González E, Johnson RA, O’Connell J, Dover JS.
J Am Acad Dermatol. 1999 Aug;41(2 Pt 1):197-202.

Intolerance of isotretinoin in a patient with anhidrotic ectodermal dysplasia.
Kirby B, Caird A, Rogers S.
Br J Dermatol. 1999 Jul;141(1):175.

Glycolic acid versus Jessner’s solution: which is better for facial acne patients? A randomized prospective clinical trial of split-face model therapy.
Kim SW, Moon SE, Kim JA, Eun HC.
Dermatol Surg. 1999 Apr;25(4):270-3.

Topical retinoyl beta-glucuronide is an effective treatment of mild to moderate acne vulgaris in Asian-Indian patients.
Goswami BC, Baishya B, Barua AB, Olson JA.
Skin Pharmacol Appl Skin Physiol. 1999 Jul-Aug;12(4):167-73.

Increased risk of sensory neuropathy in workers with chloracne after exposure to 2,3,7,8-polychlorinated dioxins and furans.
Thömke F, Jung D, Besser R, Röder R, Konietzko J, Hopf HC.
Acta Neurol Scand. 1999 Jul;100(1):1-5.

Isotretinoin treatment of a woman with bipolar disorder.
Cott AD, Wisner KL.
J Clin Psychiatry. 1999 Jun;60(6):407-8.

[Systemic treatment of acne: recommendations. The French Agency of Sanitary Safety of Health Products].
[No authors listed]
Ann Dermatol Venereol. 1999 Mar;126(3):233-4. French.

[Systemic treatment of acne: proposal. The French Agency of Sanitary Safety of Health Products].
[No authors listed]
Ann Dermatol Venereol. 1999 Mar;126(3):224-31. French.

[What is the function of « practice guidelines »?].
Revuz J.
Ann Dermatol Venereol. 1999 Mar;126(3):207-9. French.

Cosmetic problems in skin of color.
Taylor SC.
Skin Pharmacol Appl Skin Physiol. 1999 May-Jun;12(3):139-43.

Predictive factors for failure of isotretinoin treatment in acne patients: results from a cohort of 237 patients.
Lehucher-Ceyrac D, de La Salmonière P, Chastang C, Morel P.
Dermatology. 1999;198(3):278-83.

Antibacterial efficacy of benzoyl peroxide in phospholipid liposomes. A vehicle-controlled, comparative study in patients with papulopustular acne.
Fluhr JW, Barsom O, Gehring W, Gloor M.
Dermatology. 1999;198(3):273-7.

[Perimenstrual dermatoses: a comment fact of chronobiology].
Piérard-Franchimont C, Fraiture AL, Delvoye P, Dehavay J, Deleixhe-Mauhin F, Van Cauwenberge JR, Piérard GE.
Rev Med Liege. 1999 Apr;54(4):318-21. French.

Tazarotene gel is safe and effective in the treatment of acne vulgaris: a multicenter, double-blind, vehicle-controlled study.
Shalita AR, Chalker DK, Griffith RF, Herbert AA, Hickman JG, Maloney JM, Miller BH, Tschen EH, Chandraratna RA, Gibson JR, Lew-Kaya DA, Lue JC, Sefton J.
Cutis. 1999 Jun;63(6):349-54.

Is prior authorization of topical tretinoin for acne cost effective?
Feldman SR, Fleischer AB Jr, Chen GJ.
Am J Manag Care. 1999 Apr;5(4):457-63.

A lower dosage levonorgestrel and testosterone combination effectively suppresses spermatogenesis and circulating gonadotropin levels with fewer metabolic effects than higher dosage combinations.
Anawalt BD, Bebb RA, Bremner WJ, Matsumoto AM.
J Androl. 1999 May-Jun;20(3):407-14.

A is for acne.
Cornell DH.
N J Med. 1999 Jun;96(6):25-7.

Acne in adolescents. Need for treatment is more than skin deep.
Pogue SJ.
Adv Nurse Pract. 1999 Apr;7(4):53-6. Review.

Antibiotic sensitivity of Propionibacterium acnes isolates studied in a skin clinic in Singapore.
Tan HH, Goh CL, Yeo M.
Arch Dermatol. 1999 Jun;135(6):723.

Syndromes of hyperandrogenism in women.
Davis S.
Aust Fam Physician. 1999 May;28(5):447-51. Review.

[Use and adverse reactions of local antibiotics and disinfectants on the skin].
Smeenk G, Sebens FW, Houwing RH.
Ned Tijdschr Geneeskd. 1999 May 29;143(22):1140-3. Review. Dutch.

[The safety of the derivatives of retinoic acid administered topically during pregnancy].
Sabaté M, Aguilera C.
Med Clin (Barc). 1999 May 1;112(15):595-6. Spanish.

[ECLA grading: a system of acne classification for every day dermatological practice].
Dreno B, Bodokh I, Chivot M, Daniel F, Humbert P, Poli F, Clerson P, Berrou JP.
Ann Dermatol Venereol. 1999 Feb;126(2):136-41. French.

Glycolic acid peeling in the treatment of acne.
Atzori L, Brundu MA, Orru A, Biggio P.
J Eur Acad Dermatol Venereol. 1999 Mar;12(2):119-22.

Necrotizing vasculitis of the skin and uterine cervix associated with minocycline therapy for acne vulgaris.
Schrodt BJ, Kulp-Shorten CL, Callen JP.
South Med J. 1999 May;92(5):502-4.

Oral contraceptives: therapeutic uses and quality-of-life benefits–case presentations.
Sulak PJ.
Contraception. 1999 Jan;59(1 Suppl):35S-38S.

Oral contraceptive health benefits: perception versus reality.
Kaunitz AM.
Contraception. 1999 Jan;59(1 Suppl):29S-33S. Review.

Warnings on the use of isotretinoin.
Saxe N.
S Afr Med J. 1999 Apr;89(4):356.

A lifetime of healthy skin: implications for women.
Bergfeld WF.
Int J Fertil Womens Med. 1999 Mar-Apr;44(2):83-95. Review.

Split-face clinical and bio-instrumental comparison of 0.1% adapalene and 0.05% tretinoin in facial acne.
Piérard-Franchimont C, Henry F, Fraiture AL, Fumal I, Piérard GE.
Dermatology. 1999;198(2):218-22.

The effect of isotretinoin on biotinidase activity.
Schulpis KH, Georgala S, Papakonstantinou ED, Michas T, Karikas GA.
Skin Pharmacol Appl Skin Physiol. 1999 Jan-Apr;12(1-2):28-33.

Striae and acne following cardiac surgery in a child.
Goggin N, Enright F, Costigan C, Duff D, Oslizlok P, Wood AE, Watson R.
Br J Dermatol. 1999 Apr;140(4):734-6.

The quality of life in acne: a comparison with general medical conditions using generic questionnaires.
Mallon E, Newton JN, Klassen A, Stewart-Brown SL, Ryan TJ, Finlay AY.
Br J Dermatol. 1999 Apr;140(4):672-6.

The psychological and emotional impact of acne and the effect of treatment with isotretinoin.
Kellett SC, Gawkrodger DJ.
Br J Dermatol. 1999 Feb;140(2):273-82.

Acne conglobata after pregnancy.
van Pelt HP, Juhlin L.
Acta Derm Venereol. 1999 Mar;79(2):169.

Toddler-age nodulocystic acne.
Mengesha YM, Hansen RC.
J Pediatr. 1999 May;134(5):644-8.

[Bacterial resistance during anti-acne antibiotic therapy. How to limit the risk].
Piérard GE, Arrese JE, Claessens N, Greimers R, Piérard-Franchimont C, Naeyaert JM.
Rev Med Liege. 1999 Feb;54(2):100-4. French.

[Acne and thoracic pain].
Lehmann G, Marzoll I, Hein G.
Med Klin (Munich). 1999 Mar 15;94(3):170. German.

Keloid formation induced by isotretinoin therapy.
Ginarte M, Peteiro C, Toribio J.
Int J Dermatol. 1999 Mar;38(3):228-9.

Treatment outcome of acne vulgaris with oral isotretinoin in 89 patients.
Ng PP, Goh CL.
Int J Dermatol. 1999 Mar;38(3):213-6.

Propionibacterium acnes: interaction with complement and development of an enzyme-linked immunoassay for the detection of antibody.
Burkhart CG, Cantrill J, Butcher CL, Lehmann PF.
Int J Dermatol. 1999 Mar;38(3):200-3.

Face up to acne.
Adams S.
Prof Care Mother Child. 1998;8(6):142-3.

Treatment of inflamed hypertrophic scars using intralesional 5-FU.
Fitzpatrick RE.
Dermatol Surg. 1999 Mar;25(3):224-32.

Tretinoin-iontophoresis in atrophic acne scars.
Schmidt JB, Donath P, Hannes J, Perl S, Neumayer R, Reiner A.
Int J Dermatol. 1999 Feb;38(2):149-53.

Acne neonatorum: a study of 22 cases.
Katsambas AD, Katoulis AC, Stavropoulos P.
Int J Dermatol. 1999 Feb;38(2):128-30.

Stress-induced SAPHO syndrome.
Orion E, Brenner S.
J Eur Acad Dermatol Venereol. 1999 Jan;12(1):43-6.

Responsiveness of the Dermatology-specific Quality of Life (DSQL) instrument to treatment for acne vulgaris in a placebo-controlled clinical trial.
Anderson R, Rajagopalan R.
Qual Life Res. 1998 Dec;7(8):723-34.

In Vitro activity of 6 antimicrobials against propionibacteria isolates from untreated acne papulopustulosa.
Fluhr JW, Gloor M, Dietz P, Höffler U.
Zentralbl Bakteriol. 1999 Feb;289(1):53-61.

[Acne in the male resistant to isotretinoin and responsibility of androgens: 9 cases, therapeutic implications].
Chaspoux C, Lehucher-Ceyrac D, Morel P, Lefrancq H, Boudou P, Fiet J, Vexiau P.
Ann Dermatol Venereol. 1999 Jan;126(1):17-9. French.

[What indications for assessing acne in the man?].
Jamin C.
Ann Dermatol Venereol. 1999 Jan;126(1):9-10. French.

Mucosal denudation of the lips from isotretinoin therapy.
Graham BS, Barrett TL.
Arch Dermatol. 1999 Mar;135(3):349-50.

Highly positive dsDNA antibodies in minocycline-induced lupus.
Tubach F, Kaplan G, Berenbaum F.
Clin Exp Rheumatol. 1999 Jan-Feb;17(1):124-5.

Minocycline and lupuslike syndrome in acne patients.
Sturkenboom MC, Meier CR, Jick H, Stricker BH.
Arch Intern Med. 1999 Mar 8;159(5):493-7.

Pediatric tetracycline-induced pseudotumor cerbri.
Quinn AG, Singer SB, Buncic JR.
J AAPOS. 1999 Feb;3(1):53-7.

Surgical pearl: versatile paper clip comedo extractor for acne surgery.
Cvancara JL, Meffert JJ.
J Am Acad Dermatol. 1999 Mar;40(3):477-8.

Roaccutane–a dermatologist’s perspective.
Presbury D.
S Afr Med J. 1999 Jan;89(1):16-7.

Roche responds to ‘new warnings on the use of isotretinoin (Roaccutane)’.
Ebrahim O, Bredenhann M.
S Afr Med J. 1999 Jan;89(1):16.

Contributors to antibiotic resistance. Antibiotics should not be first treatment for acne.
Cheesbrough MJ.
BMJ. 1999 Mar 6;318(7184):669.

Treatment of common skin complaints–changing referral patterns.
Lyons F.
Ir Med J. 1997 Nov;90(7):260.

Spot check.
Cunningham M.
Nurs Times. 1998 Dec 30-1999 Jan 5;94(50):61-3.

A prospective survey of pediatric dermatology clinic patients in Kuwait: an analysis of 10,000 cases.
Nanda A, Al-Hasawi F, Alsaleh QA.
Pediatr Dermatol. 1999 Jan-Feb;16(1):6-11.

Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.
Ellis CN, Millikan LE, Smith EB, Chalker DM, Swinyer LJ, Katz IH, Berger RS, Mills OH Jr, Baker M, Verschoore M, Loesche C.
Br J Dermatol. 1998 Oct;139 Suppl 52:41-7.

A comparison of the efficacy and tolerability of adapalene 0.1% gel versus tretinoin 0.025% gel in patients with acne vulgaris: a meta-analysis of five randomized trials.
Cunliffe WJ, Poncet M, Loesche C, Verschoore M.
Br J Dermatol. 1998 Oct;139 Suppl 52:48-56.

Comparative tolerance of adapalene 0.1% gel and six different tretinoin formulations.
Galvin SA, Gilbert R, Baker M, Guibal F, Tuley MR.
Br J Dermatol. 1998 Oct;139 Suppl 52:34-40.

Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life.
Grosshans E, Marks R, Mascaro JM, Torras H, Meynadier J, Alirezai M, Finlay AY, Soto P, Poncet M, Verschoore M, Clucas A.
Br J Dermatol. 1998 Oct;139 Suppl 52:26-33.

Adapalene 0.1% gel has low skin irritation potential even when applied immediately after washing.
Dunlap FE, Baker MD, Plott RT, Verschoore M.
Br J Dermatol. 1998 Oct;139 Suppl 52:23-5.

Adapalene 0.1% gel for the treatment of acne vulgaris: its superiority compared to tretinoin 0.025% cream in skin tolerance and patient preference.
Dunlap FE, Mills OH, Tuley MR, Baker MD, Plott RT.
Br J Dermatol. 1998 Oct;139 Suppl 52:17-22.

Chemical stability of adapalene and tretinoin when combined with benzoyl peroxide in presence and in absence of visible light and ultraviolet radiation.
Martin B, Meunier C, Montels D, Watts O.
Br J Dermatol. 1998 Oct;139 Suppl 52:8-11.

Pharmacology of adapalene.
Michel S, Jomard A, Démarchez M.
Br J Dermatol. 1998 Oct;139 Suppl 52:3-7.

A new topical retinoid–why a new topical acne therapy?
Cunliffe WJ.
Br J Dermatol. 1998 Oct;139 Suppl 52:1-2.

Rat preputial sebocyte differentiation involves peroxisome proliferator-activated receptors.
Rosenfield RL, Kentsis A, Deplewski D, Ciletti N.
J Invest Dermatol. 1999 Feb;112(2):226-32.

Update on androgenicity.
Thorneycroft IH.
Am J Obstet Gynecol. 1999 Feb;180(2 Pt 2):288-94. Review.

Erbium laser resurfacing: current concepts.
Weinstein C.
Plast Reconstr Surg. 1999 Feb;103(2):602-16; discussion 617-8.

Hemodialysis-related nodulocystic acne treated with isotretinoin.
Lin J, Shih I, Yu C.
Nephron. 1999 Feb;81(2):146-50.

The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups.
Grimes PE.
Dermatol Surg. 1999 Jan;25(1):18-22.

Polyarteritis nodosa attributable to minocycline treatment for acne vulgaris.
Schrodt BJ, Callen JP.
Pediatrics. 1999 Feb;103(2):503-4.

[The resistance of Propionibacterium acnes and Staphylococcus epidermidis to cyclines. The Research and Study Group on Acne].
Noyon V, Legallou F, Richet H, Dreno B.
Ann Dermatol Venereol. 1998 Dec;125(12):885-7. French.

[In vitro resistance of Propionibacterium acnes and Staphylococcus epidermidis to antibiotics: should our antibiotic prescription practices for the treatment of acne be changed?].
Bourgault-Villada I.
Ann Dermatol Venereol. 1998 Dec;125(12):879-80. French.

From other ghosts of the past: acne lesion counting.
Witkowski JA, Parish LC.
J Am Acad Dermatol. 1999 Jan;40(1):131.

The principle of a three-staged operation in the surgery of acne scars.
Whang KK, Lee M.
J Am Acad Dermatol. 1999 Jan;40(1):95-7.

Antimicrobial susceptibility of Propionibacterium acnes isolated from acne vulgaris.
Kurokawa I, Nishijima S, Kawabata S.
Eur J Dermatol. 1999 Jan-Feb;9(1):25-8.